In that report, other major FXIII polymorphisms, FXIII-A p.Tyr204Phe (c.614 A > T; rs3024477), FXIII-B p.His95Arg (c.344 G > A; rs6003) and FXIII-B Intron K (IVS11 c.1952 + 144 C > G; rs12134960) were also investigated and they showed no association with stroke severity, unfavorable outcomes of therapy, therapy-associated symptomatic intracranial hemorrhage and mortality. This evidence concerns the gene F13B and Stroke.